Coppell Advisory Solutions LLC Achilles Therapeutics PLC Transaction History
Coppell Advisory Solutions LLC
- $716 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding ACHL
# of Institutions
22Shares Held
24.2MCall Options Held
0Put Options Held
0-
Syncona Portfolio LTD Guernsey, Channel Islands, X011.1MShares$15.4 Million23.86% of portfolio
-
Bml Capital Management, LLC Zionsville, IN4.1MShares$5.7 Million2.9% of portfolio
-
Fcpm Iii Services B.V. Naarden, P72.39MShares$3.32 Million0.46% of portfolio
-
Redmile Group, LLC San Francisco, CA1.61MShares$2.24 Million0.14% of portfolio
-
Vestal Point Capital, LP New York, NY1.5MShares$2.08 Million0.1% of portfolio
About Achilles Therapeutics plc
- Ticker ACHL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,774,000
- Market Cap $56.7M
- Description
- Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in ...